uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Inhibitors of tyrosine kinase inhibit the production of urokinase plasminogen activator in human prostatic cancer cells.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Genetics and Pathology.
2005 (English)In: APMIS, ISSN 0903-4641, Vol. 113, no 5, 332-9 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 113, no 5, 332-9 p.
Keyword [en]
Antineoplastic Agents/*pharmacology, Apoptosis, Cell Proliferation/drug effects, Genistein/pharmacology, Humans, Male, Prostatic Neoplasms/*enzymology, Protein Kinase Inhibitors/*pharmacology, Protein-Tyrosine Kinases/*antagonists & inhibitors, Tumor Cells; Cultured, Tyrphostins/pharmacology, Urinary Plasminogen Activator/*metabolism
Identifiers
URN: urn:nbn:se:uu:diva-10821PubMedID: 16011659OAI: oai:DiVA.org:uu-10821DiVA: diva2:38589
Available from: 2007-04-25 Created: 2007-04-25 Last updated: 2011-01-12

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16011659&dopt=Citation

Authority records BETA

Larsson, Erik

Search in DiVA

By author/editor
Larsson, Erik
By organisation
Department of Genetics and Pathology

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 347 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf